Professor , Professor of Biochemistry , Faculty of Pharmacy , Cairo University , Egypt
Tarek Mohamed Kamal Motawi is a distinguished Egyptian biochemist with a long-standing academic career. He is a Professor of Biochemistry at the Faculty of Pharmacy, Cairo University. Dr. Motawi has dedicated his career to advancing biochemistry through both teaching and research, making significant contributions to the field.
Profile
Google Scholar
Strengths for the Award
- Extensive Research Experience: Tarek Mohamed Kamal Motawi has over four decades of experience in the field of biochemistry. His career progression from Instructor to Professor at Cairo University reflects his deep expertise and commitment to the field.
- Significant Contributions to Biochemistry: Dr. Motawi’s research has covered a wide range of critical areas in biochemistry, including cancer research, neurological disorders, and endocrinology. His work on DNA methylation in cancer, the role of genetic polymorphisms in disease susceptibility, and the therapeutic effects of various compounds in disease models is particularly noteworthy.
- Prolific Publication Record: Dr. Motawi has an extensive publication record, with numerous peer-reviewed articles in reputable journals. His work is recognized internationally, and his recent publications focus on cutting-edge research in fields like epigenetics, pharmacology, and molecular biology.
- Leadership and Mentorship: As the Head of the Department of Biochemistry at Cairo University, Dr. Motawi has demonstrated strong leadership skills. His role in guiding the department and mentoring young researchers is commendable and adds to his suitability for the award.
Areas of the Improvement
- Broader Collaboration and Outreach: While Dr. Motawi has a strong publication record, there may be opportunities to enhance his research impact through broader international collaborations and participation in global research networks. This could increase the visibility of his work and lead to more interdisciplinary research opportunities.
- Involvement in Research Grants and Projects: To further strengthen his candidacy, Dr. Motawi could increase his involvement in securing and leading large-scale research grants and projects. This would not only enhance his research output but also contribute to building research capacity in his field.
Education
🎓 Dr. Motawi’s academic journey began at Cairo University, where he earned his B.Sc. in Pharmaceutical Sciences in 1976, followed by an M.Sc. in 1979. He continued his studies at the same institution, receiving his Ph.D. in Pharmaceutical Sciences with a specialization in Biochemistry in 1984.
Professional Experience
💼 Dr. Motawi’s professional career at Cairo University spans several decades. He started as an Instructor in the Department of Biochemistry in 1976, advancing through roles as Lecturer Assistant, Lecturer, Assistant Professor, and eventually becoming a full Professor of Biochemistry in 1994. He also served as the Head of the Biochemistry Department from 2008 to 2014.
Research Interests
🔬 Dr. Motawi’s research interests include cancer biochemistry, epigenetics, neurodegenerative diseases, and metabolic disorders. His work often explores the molecular mechanisms underlying these conditions, with a focus on developing novel therapeutic strategies.
Awards and Recognition
🏆 Throughout his career, Dr. Motawi has been recognized for his contributions to science and academia. His dedication to research and teaching has earned him numerous accolades, reflecting his impact on the field of biochemistry and his commitment to advancing knowledge.
Publications
📚 Dr. Motawi has an extensive list of publications in peer-reviewed journals. Here are some of his recent works:
- Cromolyn chitosan nanoparticles reverse the DNA methylation of RASSF1A and p16 genes
Chem Biol Interact, 2022. Cited by 10 articles.
Link
- Empagliflozin alleviates endoplasmic reticulum stress and augments autophagy in rotenone-induced Parkinson’s disease in rats
Chem Biol Interact, 2022. Cited by 8 articles.
Link
- rs62139665 polymorphism in the promoter region of EpCAM is associated with hepatitis C virus-related hepatocellular carcinoma risk in Egyptians
Front Oncol, 2022. Cited by 15 articles.
Link
- Impact of FOXP1 rs2687201 genetic variant on the susceptibility to HCV-related hepatocellular carcinoma in Egyptians
J Biochem Mol Toxicol, 2021. Cited by 12 articles.
Link
- Genetic and epigenetic control on clock genes in multiple sclerosis
J Genet Genomics, 2021. Cited by 9 articles.
Link
Conclusion
Dr. Tarek Mohamed Kamal Motawi is an outstanding candidate for the Best Researcher Award, given his extensive research contributions, leadership, and commitment to advancing the field of biochemistry. His prolific publication record and significant impact on disease-related biochemical research make him a strong contender for this recognition. While there is always room for enhancing international collaborations and project leadership, Dr. Motawi’s achievements make him a highly deserving candidate for this prestigious award.